Martin Ogletree

Martin Ogletree has had a long and successful career in the pharmaceutical industry. Martin began their career at Merck, where they worked for two years as the CV Franchise TIDV Lead and Director of Thrombosis Biology Research. Martin then moved to Cumberland Pharmaceuticals, where they served as Director of Development for two years. In this role, they were responsible for preparing the original IND for N-acetylcysteine and leading the technology transfer and collaboration with Vanderbilt University Medical Center on the clinical development of ifetroban. Martin then founded their own company, Points & Assists, LLC, where they served as Owner for six years. In their current role as Advisor at Cloud Pharmaceuticals, they provide strategic advice and guidance to the company on a variety of topics related to the pharmaceutical industry.

Martin Ogletree has a Ph.D. in Cardiovascular Physiology from Thomas Jefferson University Hospitals and a BA in Biology from Swarthmore College.